HSCS Heart Test Laboratories, Inc.: Business Value to Revenue

Official company branding of heartsciences.com (HSCS)

Heart Test Laboratories is implementing AI diagnostics for cardiac pathologies, which is temporarily rendering cash flows volatile. The enterprise value-to-revenue multiple demonstrates a pivot driven by cardiologists' recognition of system accuracy and the current sales rollout, which is presently constrained by high costs. The value of 0.00 represents the current metric, capturing market expectations for the scaling of software solutions.

HSCS (Heart Test Labs) Company Value to Revenue history from 11/23/2025 to 11/19/2026

heartsciences.com - analytical breakdowns and key metrics (HSCS)

- current quotes and average value forecast:
Initial company analysis:HSCS (HeartSciences)
Manufactured products of Heart Test Laboratories

Identifying fundamentally resilient assets requires analyzing the enterprise value relative to generated revenue. This indicator measures market capitalization plus debt divided by revenue, allowing for a real-time assessment of the actual value of Heart Test Laboratories (HSCS) AI diagnostic systems while eliminating financial distortions; by tracking changes in the EV/Sales multiple, an investor can determine whether the company's technological leadership premium aligns with its actual sales.

Direct competitors

A (Agilent) - Company Value to Revenue Ratio|DGX (Quest Diagnostics) - Company Value to Revenue|Illumina Inc (ILMN) - EV/Sales Multiple|Company Value to Revenue EXAS|Revvity, Inc. (RVTY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple BIO|NNNN (Anbio Biotechnology) - Business Value to Revenue|EV/Sales Multiple SHC (Sotera Health)|Quidel Corporation (QDEL) - Enterprise Value-to-Revenue Multiple|OPK - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio CareDx Corp CDNA|Maravai LifeSciences (MRVI) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Sales Ratio Fulgent Genetics, Inc. FLGT|LAB (Standard BioTools Inc) - EV/Sales Multiple|Cytek Biosciences (CTKB) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple OSUR|Exagen - Company Value to Revenue Ratio|EV/Sales Multiple MDXH (MDxHealth, Inc.)|luciddx.com (LUCD) - Enterprise Value-to-Revenue Multiple|prenetics.com - EV/Sales Multiple|Insight Molecular Diagnostics, Inc. (IMDX) - Company Value to Revenue|TRIB: EV/Sales Multiple|ProPhase - Business Value to Revenue|Enterprise Value-to-Revenue Ratio ainos.com|CODX: Business Value to Revenue|Enterprise Value-to-Revenue Ratio Biomerica Inc. (BMRA)|Total Company Value-to-Revenue Ratio Cardio Diagnostics Holdings|EV/Sales Multiple ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Enterprise Value-to-Revenue Multiple|bluejaydx.com - EV/Sales Multiple|Aspira Women's Health - Enterprise Value-to-Revenue Coefficient|AXDX (Accelerate Diagnostics) - Company Value to Revenue|Company Value to Revenue CENTOGENE, N.V.|Enterprise Value-to-Revenue Ratio enzo.com|EV/Sales Multiple Fresh2 Group Limited|EV/Sales Multiple GENE|23andMe Holding Co. - Company Value to Revenue Ratio|Psychemedics Inc - Company Value to Revenue